Hemocoagulase, also known as batroxobin, is a natural enzyme derived from the venom of the South American pit viper, Bothrops atrox. It possesses hemostatic properties and is used to promote blood clotting and control bleeding during various medical procedures.
Used in Medical Industry:
Hemocoagulase is used as a hemostatic agent for promoting blood clotting and controlling bleeding during surgery, particularly in cardiac and vascular procedures. It achieves this by converting fibrinogen into fibrin, which forms a stable blood clot to stop bleeding.
Used in Treatment of Bleeding Disorders:
Hemocoagulase is used as a therapeutic agent for the treatment of chronic and acute bleeding disorders, such as hemophilia and von Willebrand disease. It helps manage and control bleeding episodes in these conditions by enhancing the blood clotting process.
However, it is important to note that hemocoagulase should be used with caution and under the guidance of a healthcare professional, as it can lead to adverse reactions such as allergic responses and anaphylaxis in some individuals.